Insights into angiotensin II receptor function through AT2 receptor knockout mice.

Angiotensin II signals via at least two receptors termed AT1 and AT2. The function of the AT1 receptor is well defined, while that of the AT2 receptor is still shrouded in uncertainty. AT2 gene-deficient (-/-) mice have been helpful in unravelling the function of the AT2 receptor. We have studied AT2-/- and AT2+/+ mice with classical physiological techniques developed for the rat. We found that although AT2-/- mice have normal glomerular filtration rate, the pressure-natriuresis relationship in these mice, compared with AT2+/+ mice, is shifted rightward. Moreover, medullary blood flow fails to increase with increased perfusion pressure while the AT1 receptor expression in the kidneys is increased. We used telemetry and found that AT2-/- mice have about 10 mmHg higher blood pressures than AT2+/+ mice and that their circadian rhythm is disturbed. Moreover, their baroreflexes, as measured by spectral analyses, differs from AT2+/+ controls. The cardiac function of AT2-/- mice is remarkably preserved and the differences are subtle. However, if the mice are given l-NAME hypertension, they exhibit an end-systolic pressure-volume relationship that reveals decreased contractility and probable increased vascular stiffness. Furthermore, the hearts of AT2-/- mice hypertrophy more in response to l-NAME than those of AT2+/+ mice and perivascular fibrosis is increased. DOCA-salt treatment also shows a more rightward pressure-natriuresis relationship in AT2-/- compared with AT2+/+ mice. The renal iNOS expression is increased with DOCA-salt treatment. Our findings support the notion that the AT2 receptor signals antiproliferative and antifibrotic effects and that its presence results in lower blood pressures and lesser responses to secondary forms of hypertension. Technical advances that have allowed us to adapt methods for the rat to the much smaller mouse have facilitated our studies.

[1]  F. Luft,et al.  Nitric oxide synthase expression in AT2 receptor-deficient mice after DOCA-salt. , 2004, Kidney international.

[2]  F. Luft,et al.  Cardiac hypertrophy and fibrosis in chronic l-NAME-treated AT2 receptor-deficient mice , 2004, Journal of hypertension.

[3]  D. Kass,et al.  Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.

[4]  M. Wellner,et al.  Pressure natriuresis in AT(2) receptor-deficient mice with L-NAME hypertension. , 2003, Journal of the American Society of Nephrology : JASN.

[5]  R. Freeman,et al.  Angiotensin II's Antiproliferative Effects Mediated Through AT2-Receptors Depend On Down-Regulation of SM-20 , 2002, Laboratory Investigation.

[6]  A. Diedrich,et al.  Heart Rate Variability and Baroreflex Function in AT2 Receptor-Disrupted Mice , 2002, Hypertension.

[7]  R. Stevenson,et al.  AGTR2 Mutations in X-Linked Mental Retardation , 2002, Science.

[8]  T. Ichiki,et al.  Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension , 2001, Circulation.

[9]  J. Blanco,et al.  Systemic Infusion of Angiotensin II into Normal Rats Activates Nuclear Factor-κB and AP-1 in the Kidney : Role of AT1 and AT2 Receptors , 2001 .

[10]  T. Walther,et al.  Left ventricular function in mice lacking the AT2 receptor , 2001, Journal of hypertension.

[11]  F. Gaffney,et al.  Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. , 2000, The Journal of clinical investigation.

[12]  R. Plehm,et al.  Long‐term blood pressure telemetry in AT2 receptor‐disrupted mice , 2000, Journal of hypertension.

[13]  J. Sadoshima Cytokine actions of angiotensin II. , 2000, Circulation research.

[14]  T. Walther,et al.  Inhibition of pressure natriuresis in mice lacking the AT2 receptor. , 2000, Kidney international.

[15]  J. Polak,et al.  Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats. , 1999, Journal of the American Society of Nephrology : JASN.

[16]  R. Carey,et al.  Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Ichiki,et al.  Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. , 1999, Biochemical and biophysical research communications.

[18]  Y. Mori,et al.  Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. , 1998, The Journal of clinical investigation.

[19]  A. Danser,et al.  Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. , 1997, Journal of molecular and cellular cardiology.

[20]  B. Lévy,et al.  Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. , 1996, The Journal of clinical investigation.

[21]  B. Hogan,et al.  Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor , 1995, Nature.

[22]  Brian K. Kobilka,et al.  Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice , 1995, Nature.

[23]  P. Timmermans,et al.  Proposed update of angiotensin receptor nomenclature. , 1995, Hypertension.

[24]  H. Inui,et al.  Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. , 1993, The Journal of biological chemistry.